This inventor holds 1 USPTO granted patent and 3 published patent applications and 4 EPO patents. Top assignee: Roche Diagnostics Operations, Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Innovations of Markus Thomas in Atrial Fibrillation Prediction
Introduction
Markus Thomas is an accomplished inventor based in Rheinfelden, Germany. He has made significant contributions to the field of medical diagnostics, particularly in predicting the recurrence of atrial fibrillation. His innovative approach utilizes biomarkers to enhance patient care and treatment outcomes.
Latest Patents
Markus Thomas holds a patent for a method titled "Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fibrillation." This patent describes a method for predicting the risk of recurrence of atrial fibrillation in a subject by measuring the amount of the biomarker Angiopoietin-2 (Ang-2) and optionally at least one further biomarker in a sample from the subject. Additionally, the patent outlines a method for diagnosing atrial fibrillation based on similar measurements. Devices adapted to carry out this method are also described in the patent.
Career Highlights
Throughout his career, Markus Thomas has worked with prominent companies in the healthcare sector, including Roche Diagnostics Operations, Inc. and Roche Diagnostics GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in medical diagnostics.
Collaborations
Markus has collaborated with notable professionals in his field, including Herbert Andres and Dirk Block. These collaborations have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Markus Thomas is a notable inventor whose work in predicting atrial fibrillation recurrence through biomarker analysis represents a significant advancement in medical diagnostics. His contributions continue to impact the healthcare industry positively.